The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Gene Therapy Medicine-Global Market Insights and Sales Trends 2024
Synopsis
The global Gene Therapy Medicine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Gene Therapy Medicine in various end use industries. The expanding demands from the Cancer, Monogenic, Infectious Disease and Cardiovascular Disease, are propelling Gene Therapy Medicine market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injection segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Gene Therapy Medicine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Gene Therapy Medicine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Gene Therapy Medicine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Gene Therapy Medicine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Gene Therapy Medicine covered in this report include Bluebird Bio, Sangamo, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical Inc. and Advantagene, etc.
The global Gene Therapy Medicine market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bluebird Bio
Sangamo
Spark Therapeutics
Dimension Therapeutics
Avalanche Bio
Celladon
Vical Inc.
Advantagene
Global Gene Therapy Medicine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Gene Therapy Medicine market, Segment by Type:
Oral
Injection
Global Gene Therapy Medicine market, by Application
Cancer
Monogenic
Infectious Disease
Cardiovascular Disease
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Gene Therapy Medicine companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Gene Therapy Medicine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Gene Therapy Medicine in various end use industries. The expanding demands from the Cancer, Monogenic, Infectious Disease and Cardiovascular Disease, are propelling Gene Therapy Medicine market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injection segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Gene Therapy Medicine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Gene Therapy Medicine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Gene Therapy Medicine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Gene Therapy Medicine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Gene Therapy Medicine covered in this report include Bluebird Bio, Sangamo, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical Inc. and Advantagene, etc.
The global Gene Therapy Medicine market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bluebird Bio
Sangamo
Spark Therapeutics
Dimension Therapeutics
Avalanche Bio
Celladon
Vical Inc.
Advantagene
Global Gene Therapy Medicine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Gene Therapy Medicine market, Segment by Type:
Oral
Injection
Global Gene Therapy Medicine market, by Application
Cancer
Monogenic
Infectious Disease
Cardiovascular Disease
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Gene Therapy Medicine companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Gene Therapy Medicine
1.1 Gene Therapy Medicine Market Overview
1.1.1 Gene Therapy Medicine Product Scope
1.1.2 Gene Therapy Medicine Market Status and Outlook
1.2 Global Gene Therapy Medicine Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Gene Therapy Medicine Market Size by Region (2018-2029)
1.4 Global Gene Therapy Medicine Historic Market Size by Region (2018-2023)
1.5 Global Gene Therapy Medicine Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Gene Therapy Medicine Market Size (2018-2029)
1.6.1 North America Gene Therapy Medicine Market Size (2018-2029)
1.6.2 Europe Gene Therapy Medicine Market Size (2018-2029)
1.6.3 Asia-Pacific Gene Therapy Medicine Market Size (2018-2029)
1.6.4 Latin America Gene Therapy Medicine Market Size (2018-2029)
1.6.5 Middle East & Africa Gene Therapy Medicine Market Size (2018-2029)
2 Gene Therapy Medicine Market by Type
2.1 Introduction
2.1.1 Oral
2.1.2 Injection
2.2 Global Gene Therapy Medicine Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Gene Therapy Medicine Historic Market Size by Type (2018-2023)
2.2.2 Global Gene Therapy Medicine Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Gene Therapy Medicine Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Gene Therapy Medicine Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Gene Therapy Medicine Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Gene Therapy Medicine Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Gene Therapy Medicine Revenue Breakdown by Type (2018-2029)
3 Gene Therapy Medicine Market Overview by Application
3.1 Introduction
3.1.1 Cancer
3.1.2 Monogenic
3.1.3 Infectious Disease
3.1.4 Cardiovascular Disease
3.1.5 Other
3.2 Global Gene Therapy Medicine Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Gene Therapy Medicine Historic Market Size by Application (2018-2023)
3.2.2 Global Gene Therapy Medicine Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Gene Therapy Medicine Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Gene Therapy Medicine Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Gene Therapy Medicine Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Gene Therapy Medicine Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Gene Therapy Medicine Revenue Breakdown by Application (2018-2029)
4 Gene Therapy Medicine Competition Analysis by Players
4.1 Global Gene Therapy Medicine Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gene Therapy Medicine as of 2022)
4.3 Date of Key Players Enter into Gene Therapy Medicine Market
4.4 Global Top Players Gene Therapy Medicine Headquarters and Area Served
4.5 Key Players Gene Therapy Medicine Product Solution and Service
4.6 Competitive Status
4.6.1 Gene Therapy Medicine Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bluebird Bio
5.1.1 Bluebird Bio Profile
5.1.2 Bluebird Bio Main Business
5.1.3 Bluebird Bio Gene Therapy Medicine Products, Services and Solutions
5.1.4 Bluebird Bio Gene Therapy Medicine Revenue (US$ Million) & (2018-2023)
5.1.5 Bluebird Bio Recent Developments
5.2 Sangamo
5.2.1 Sangamo Profile
5.2.2 Sangamo Main Business
5.2.3 Sangamo Gene Therapy Medicine Products, Services and Solutions
5.2.4 Sangamo Gene Therapy Medicine Revenue (US$ Million) & (2018-2023)
5.2.5 Sangamo Recent Developments
5.3 Spark Therapeutics
5.3.1 Spark Therapeutics Profile
5.3.2 Spark Therapeutics Main Business
5.3.3 Spark Therapeutics Gene Therapy Medicine Products, Services and Solutions
5.3.4 Spark Therapeutics Gene Therapy Medicine Revenue (US$ Million) & (2018-2023)
5.3.5 Dimension Therapeutics Recent Developments
5.4 Dimension Therapeutics
5.4.1 Dimension Therapeutics Profile
5.4.2 Dimension Therapeutics Main Business
5.4.3 Dimension Therapeutics Gene Therapy Medicine Products, Services and Solutions
5.4.4 Dimension Therapeutics Gene Therapy Medicine Revenue (US$ Million) & (2018-2023)
5.4.5 Dimension Therapeutics Recent Developments
5.5 Avalanche Bio
5.5.1 Avalanche Bio Profile
5.5.2 Avalanche Bio Main Business
5.5.3 Avalanche Bio Gene Therapy Medicine Products, Services and Solutions
5.5.4 Avalanche Bio Gene Therapy Medicine Revenue (US$ Million) & (2018-2023)
5.5.5 Avalanche Bio Recent Developments
5.6 Celladon
5.6.1 Celladon Profile
5.6.2 Celladon Main Business
5.6.3 Celladon Gene Therapy Medicine Products, Services and Solutions
5.6.4 Celladon Gene Therapy Medicine Revenue (US$ Million) & (2018-2023)
5.6.5 Celladon Recent Developments
5.7 Vical Inc.
5.7.1 Vical Inc. Profile
5.7.2 Vical Inc. Main Business
5.7.3 Vical Inc. Gene Therapy Medicine Products, Services and Solutions
5.7.4 Vical Inc. Gene Therapy Medicine Revenue (US$ Million) & (2018-2023)
5.7.5 Vical Inc. Recent Developments
5.8 Advantagene
5.8.1 Advantagene Profile
5.8.2 Advantagene Main Business
5.8.3 Advantagene Gene Therapy Medicine Products, Services and Solutions
5.8.4 Advantagene Gene Therapy Medicine Revenue (US$ Million) & (2018-2023)
5.8.5 Advantagene Recent Developments
6 North America
6.1 North America Gene Therapy Medicine Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Gene Therapy Medicine Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy Medicine Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Gene Therapy Medicine Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy Medicine Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Gene Therapy Medicine Market Dynamics
11.1 Gene Therapy Medicine Industry Trends
11.2 Gene Therapy Medicine Market Drivers
11.3 Gene Therapy Medicine Market Challenges
11.4 Gene Therapy Medicine Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
